SHANGRAO, China, Dec. 12, 2023 /PRNewswire/ — JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has been honoured with the PV Magazine Publisher’s Pick Award 2023 for its latest commercial and industrial energy storage system SunGiga. This prestigious recognition highlights JinkoSolar’s exceptional contribution to the renewable industry.

JinkoSolar’s new SunGiga has an intelligent power conversion system and multiple liquid cooling control modes that lower consumption by 30% and, compared with a standard air-cooling system, SunGiga’s space utilization rate is higher by 38%. The modular and pre-assembled design makes installation and maintenance as well as future capacity augmentation easier and faster.

The SunGiga BESS’s distinctive liquid-cooling structural design not only optimizes heat dissipation but also significantly enhances the overall energy density of the system. Thanks to this breakthrough innovation, less space is required to house the 215 kWh of battery capacity.

Safety is a paramount at JinkoSolar. This is parfticularly evident in the comprehensive multi-layer safety protection integrated into the SunGiga BESS at the battery electrical and system levels. Intelligent battery monitoring technology ensures high-precision online monitoring of the battery status, offering timely and accurate alerts to prevent thermal runaway.

Ms. Dany Qian, Vice President of JinkoSolar, commented: "We are very proud to receive this prestigious award from PV Magazine for our advanced ESS solutions. This award is a testament to our steadfast commitment to advancing secure, efficient, and groundbreaking solutions in the field of renewable energy. Together with our state-of-the-art modules, our solar-plus-storage comprehensive solution optimized for C&I markets help our customers enjoy cheaper power, achieve energy security and decarbonize their operations. JinkoSolar remains fully committed to be a trailblazer in shaping the future of sustainable energy solutions for the benefit of humanity."

About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions.

JinkoSolar had 14 productions facilities globally, 24 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, Brazil, Chile, Australia, Canada, Malaysia, the United Arab Emirates, Denmark, Indonesia, Nigeria and Saudi Arabia, and global sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of September 30, 2023.

To find out more, please see: www.jinkosolar.com

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company’s operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar’s filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor and media inquiries, please contact:

Ms. Stella Wang
JinkoSolar Holding Co., Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: [email protected] 

Source : JinkoSolar BESS SunGiga Receives PV Magazine's Publisher's Pick Award 2023

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SHANGHAI, Dec. 12, 2023 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) announced that the NDA for new indication of HANSIZHUANG, serplulimab, an innovative anti-PD-1 mAb independently developed by the company, in combination with chemotherapy as a first-line treatment for patients with locally advanced or metastatic non-squamous non-small cell lung cancer (nsNSCLC) has been accepted by the National Medical Products Administration (NMPA), which is the fifth indication for HANSIZHUANG accepted by the NMPA. To date, HANSIZHUANG has been approved for the treatment of microsatellite instability-high (MSI-H) solid tumors, squamous non-small cell lung cancer (sqNSCLC), extensive-stage small cell lung cancer (ES-SCLC) and esophageal squamous cell carcinoma (ESCC).

Lung cancer is the cancer with the highest global mortality rate. According to the latest data released by the International Agency for Research on Cancer (IARC) of the World Health Organization, the number of cancer deaths worldwide in 2020 reached 9.96 million, of which approximately 1.8 million died from lung cancer, accounting for 18%. In China, the incidence rate and mortality of lung cancer rank first, and the incidence rate is increasing year by year. The non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, accounting for about 85% of lung cancer patients, among which nsNSCLC has the highest incidence rate. In the treatment of NSCLC, immune checkpoint inhibitors (ICI), such as PD-1/PD-L1, have developed rapidly, notably, the anti-PD-1 mAb plus chemotherapy has been recommended by the latest NCCN guidelines and CSCO guidelines as the first-line treatment for nsNSCLC, and serplulimab therefore is expected to bring a new option for patients.

The NDA for new indication of HANSIZHUANG is mainly based on a randomized, double-blind, multi-center phase 3 clinical study of HANSIZHUANG in combination with chemotherapy, or chemotherapy as a first-line treatment for patients with advanced non-squamous non-small cell lung cancer. The study results demonstrated that HANSIZHUANG in combination with chemotherapy significantly prolonged progression-free survival (PFS) compared with chemotherapy, which has met the pre-specified superiority criteria, with good safety and no detection of new safety signal.

HANSIZHUANG, Henlius’ first self-developed innovative monoclonal antibody, focuses on lung and gastrointestinal cancer and has initiated more than 10 clinical studies on immuno-oncology combination therapies worldwide. It covers the full range of first-line treatment of lung cancer, in which a head-to-head bridging trial of HANSIZHUANG versus first-line standard-of-care atezolizumab for ES-SCLC was launched in the U.S. in 2022, which is beneficial for its registration and commercialization in the U.S. In addition, the Marketing Authorization Application (MAA) for HANSIZHUANG on ES-SCLC has been validated by the European Medicines Agency (EMA), with approval expected in the first half of 2024. Previously, HANSIZHUANG was also granted orphan drug designations by the U.S. Food and Drug Administration (FDA) and European Commission (EC) for the treatment of SCLC. Furthermore, Henlius is steadily advancing a global phase 3 multi-center clinical research of HANSIZHUANG for the limited stage small cell lung cancer (LS-SCLC) and its first patients in China, the U.S., Europe, and Australia have been dosed, respectively.

In the future, Henlius will continue to improve its innovation capabilities to meet patients’ needs and create greater clinical value, aiming to provide more accessible, affordable, and high-quality products and solutions to patients around the world.

About HANSIZHUANG

HANSIZHUANG (recombinant humanized anti-PD-1 monoclonal antibody injection, generic name: serplulimab injection) is the first anti-PD-1 mAb for the first-line treatment of SCLC. Up to date, 4 indications are approved for marketing in China, 2 marketing applications are under review in China and the EU, and more than 10 clinical trials are ongoing across the world.

HANSIZHUANG was launched in March 2022 and has been approved by the NMPA for the treatment of MSI-H solid tumours, squamous non-small cell lung cancer (sqNSCLC), extensive-stage small cell lung cancer (ES-SCLC), and esophageal squamous cell carcinoma (ESCC). Its marketing application of the first-line treatment for ES-SCLC is under review by the EMA. Focusing on lung and gastrointestinal cancer, the synergy of HANSIZHUANG with in-house products of the company and innovative therapies are being actively promoted. It has successively obtained clinical trial approvals in China, the U.S., the EU and other countries and regions to initiate more than 10 clinical trials on immuno-oncology combination therapies in a wide variety of indications. As of now, the company has enrolled more than 3,600 subjects in China, the U.S., Turkey, Poland, Georgia and other countries and regions, and the proportion of White is over 30% in two MRCTs, making HANSIZHUANG an anti-PD-1 mAb with one of the largest global clinical data pools. The results of 3 pivotal trials of HANSIZHUANG were published in the Journal of the American Medical Association (JAMA), Nature Medicine and the British Journal of Cancer, respectively. Furthermore, HANSIZHUANG was recommended by the CSCO Guidelines for Small Cell Lung Cancer, the CSCO Guidelines for Non-Small Cell Lung Cancer, the CSCO Guidelines for Esophageal Cancer, the CSCO Guidelines for Colorectal Cancer, the CSCO Clinical Practice Guidelines on Immune Checkpoint Inhibitor, the China Guidelines for Radiotherapy of Esophageal Cancer, and other definitive guides, providing valuable references for clinical diagnosis and treatment of tumours. On the other hand, serplulimab was granted orphan drug designations by the U.S. FDA and the EC for the treatment of SCLC, and its bridging head-to-head trial in the United States to compare HANSIZHUANG to standard of care atezolizumab (anti-PD-L1 mAb) for the first-line treatment of ES-SCLC is well under way.

About Henlius

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable, and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases, and ophthalmic diseases. Up to date, 5 products have been launched in China, 1 has been approved for marketing in overseas markets, 19 indications are approved worldwide, and 3 marketing applications have been accepted for review in China, the U.S., and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centers and Shanghai-based manufacturing facilities in line with global Good Manufacturing Practice (GMP), including Xuhui Plant certificated by China and the EU GMP and Songjiang First Plant certificated by China GMP.

Henlius has pro-actively built a diversified and high-quality product pipeline covering over 20 innovative monoclonal antibodies (mAbs) and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as backbone. Apart from the launched products HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab for injection, trade name in Europe: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®), the first China-developed mAb biosimilar approved both in China and Europe, HANDAYUAN (adalimumab) and HANBEITAI (bevacizumab), the innovative product HANSIZHUANG has been approved by the NMPA for the treatment of MSI-H solid tumors, squamous non-small cell lung cancer (sqNSCLC) and extensive-stage small cell lung cancer (ES-SCLC), and esophageal squamous cell carcinoma (ESCC), making it the world’s first anti-PD-1 mAb for the first-line treatment of SCLC. What’s more, Henlius has conducted over 30 clinical studies for 16 products, expanding its presence in major markets as well as emerging markets.

Source : The NDA for New Indication of Henlius Anti-PD-1 mAb Serplulimab in Combination with Chemotherapy for the First-line Treatment of non-squamous NSCLC Accepted by the NMPA

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

CHANGSHA, China, Dec. 12, 2023 /PRNewswire/ — Divas Hit the Road ("the Show"), a hit travel reality show co-produced and launched by Hunan TV and Mango TV, has returned for the fifth season with a new theme that takes audiences on a global-trotting journey in countries along the Belt and Road Initiative (BRI). Celebrating BRI’s tenth anniversary, the new season sees seven Chinese celebrities — actresses Dilraba Dilmurat, Qin Lan, Qin Hailu, Xin Zhilei, and Zhao Zhaoyi, and actors Wang Anyu and Hu Xianxu – go on a low-budget yet eye-opening adventure starting from Saudi Arabia, then traversing northwards to Croatia and reaching the scenic landscapes of Iceland, where they offer a close-up look at the local cultures and allow viewers to live vicariously their exotic experiences.

The popular program has played a positive role in global cultural exchanges, opening a vivid cultural window for China and countries communicating along the BRI. For instance, Croatian locals exchanged gifts with Chinese guests and shared stories about the transformative impact of a Chinese-led bridge construction. Saudi residents and Chinese guests learn each other’s language to write "Love and peace."

Audiences will also be taken to some of the most beautiful destinations along the tour, including those that highlight the fruitful outcomes of BRI. Haramain High-Speed Rail, with a total length of 450.28 kilometers, constructed by China Railway 18th Bureau Group, is a major infrastructure project cutting through desert terrain, reducing the travel time from 5-6 hours to less than 2 hours. A landmark structure in southern Croatia, the Peljesac Bridge is the largest infrastructure project undertaken by China in the European Union. The bridge, spanning 2,440 meters in length, links up the Croatian mainland with the Peljesac Peninsula, bridging the north and south parts of Croatia.

Since the program began airing on Mango TV and Hunan TV, the show has led to a surge in travel enthusiasm for Silk Road among internet audiences, with online travel platforms clocking an over 772% jump in the search for the keywords related to "Saudi Arabia".

With its focus on fostering international friendships, the Show aims to promote cultural exchanges. As they experienced the exotic locales through the riveting cultural expedition, the seven featured guests, along with the production team, brought Chinese cultures to the local families they visited, strengthening the understanding and appreciation between different nations.

In an episode dedicated to discovering the beauty of Croatia, Diliraba, a talented actress from Xinjiang, China, adorned in Xinjiang’s ethnic cultural attire, the Etles dress, presented an eye-catching performance of traditional Xinjiang dance. This act sparked a fervor for Chinese national culture on the internet, creating a buzz in online communities worldwide. The stunning dance captivated international audiences, who were mesmerized by traditional Chinese ethnic costumes, deeply immersing themselves in the allure of Chinese cultural charm.

To watch the Show, please visit https://w.mgtv.com/b/593651.html.

Source : Chinese Reality Show "Divas Hit the Road" Invites Viewers to Experience the Charm of Silk Road, Serving as a Portal for International Cultural Exchanges

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SINGAPORE, Dec. 12, 2023 /PRNewswire/ — NiceHash, the world’s leading hashpower marketplace, featured in Forbes and Coinbureau, has launched their outstanding one-of-a-kind EasyMining platform with fast wallet registration, awesome tools and choice of low fee mining packages.

NiceHash is a cloud crypto mining hashpower platform founded in 2014 by two Slovenian university students, that has grown into the largest marketplace on the planet, supporting more than 250,000 daily active miners and more than 1 million miners total users across 190 countries.

As a global hashpower broker and cryptocurrency exchange, NiceHash is an open marketplace that connects sellers of hashing power with buyers of hashing power using the sharing economy approach.

NiceHash Miners can easily buy time on CPU, GPU, and ASIC mining rigs to start earning crypto. Alternatively, they can sell their existing mining capacity to other miners to earn income. It is a powerful platform for miners who want to get into Bitcoin mining without setting up their own data centre.

NiceHash is a legitimate platform with a number of safety measures in place to protect users’ accounts and funds. These include SSL encryption, 2-factor authentication, and email alerts about all activity on a user’s account.

Unique Benefits and Advantages.
Users can mine cryptocurrencies with as little as 0.001 BTC.
Supports 34 different mining algorithms and dozens of cryptocurrencies.
Quick Miner automated mining software is easy to use.
Enables anyone to sell hashpower for mining.
Offers short-term mining solutions (less than one day)
No contracts

First Mining platform of its kind.
Fast User Friendly Website / App Experience
24/7 multilingual customer support
Low Fees
Multi language

Outstanding Key Features:

Hashpower Marketplace
The hashpower marketplace is at the heart of NiceHash mining. This is where miners and hashpower providers come together. Prices in the marketplace are automatically updated every 10 seconds in response to changing crypto prices, varying hashpower availability, and changing demand from miners.

QuickMiner
Quick Miner is an easy-to-use software developed by NiceHash specifically for NiceHash users. It is fully secure and enables miners to start mining on their own computer or on rented hashpower within seconds.

Profitability Calculator
The NiceHash profitability calculator is designed for hashpower sellers. It enables you to enter details about a mining rig and associated electricity costs then determine potential daily profits from mining.

CPU, GPU, and ASIC Mining
Notably, the hashpower marketplace supports CPU, GPU, and ASIC mining. Different mining rigs are suitable for mining different tokens, so this enables miners to focus on whatever mining algorithm and token combination is most profitable at any time.

EasyMining is the easiest way to mine bitcoin and many other cryptocurrencies. It enables anyone to start mining with no prior knowledge, and all the complexity is removed. Users can simply select the coin they want to mine and let the platform take care of the mining.

Register via the link here now to Access All NiceHash Outstanding Mining Packages

Source : NICEHASH, WORLD LEADING CRYPTO MINING PLATFORM LAUNCHES IN ASIA

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Nobel Laureates, Captains of Industry, Former Heads of State and Civil Society Leaders Unite, Calling for Unconditional Release of Ethnic Armenians Illegally Held in Azerbaijan

Failure to release most prominent prisoners demonstrates political retribution by Baku; Calls for sanctions against the Aliyev regime mounting in the US Congress and the European Parliament

Letter signed by former presidents Mary Robinson, Ernesto Zedillo, Nobel Prize Winners Leymah Gbowee and Oscar Arias, Elisha Wiesel, Chairman of the Board of the Elie Wiesel Foundation for Humanity, entrepreneurs Richard Branson, Marc Benioff, publisher Ariana Huffington, and other global figures highlights concerns for detained leaders from Nagorno-Karabakh, including Armenian humanitarian Ruben Vardanyan.

BRUSSELS, Dec. 12, 2023 /PRNewswire/ — Nobel Prize laureates, business leaders, former heads of state, and humanitarians are among the more than 100 global figures who have signed a letter calling for the immediate and unconditional release of the "Armenian Prisoners," which includes eight Armenian political prisoners, who are former leaders of Nagorno-Karabakh’s government illegally detained following Azerbaijan’s invasion and seizure of the region in September. More than a dozen other prisoners of war arrested during the conflict also remain in custody.

The collective plea echoes growing concerns over conditions and treatment of these imprisoned individuals, including prominent Armenian businessman and humanitarian, Ruben Vardanyan. Their arrest follows a campaign of ethnic cleansing by the Azerbaijani forces. While the December 7th release of 32 Armenian prisoners of war is a welcome first step, all of the others must be released.  The failure of Baku to release the remaining eight political prisoners raises deep concerns over the motives by the Aliyev regime of their continued detention.  

"The human rights abuses witnessed in the wake of the Nagorno-Karabakh conflict demand urgent attention and action," said Noubar Afeyan, another signatory as well as the co-founder of the Aurora Humanitarian Initiative. "President Aliyev chooses political retribution over justice.  We believe in the inherent dignity and rights of every individual and call on the international community to join us in condemning this injustice."

Afeyan has long collaborated on global and regional economic development and humanitarian projects with Vardanyan, who has become a symbol of the broader struggle for political freedom and human dignity in the region. His unjust imprisonment has galvanized some of the world’s most respected voices to champion his cause and that of others unjustly detained.

"We call on President Aliyev to fulfill his obligations to international rules and law, ensuring those unjustly imprisoned can return safely to their families," said Paul Polman, Vice Chair of the United Nations Global Compact and former CEO of Unilever. "All individuals in Nagorno-Karabakh have a right to experience a life of peace and security, including the freedom to move without hindrance or the looming specter of inhuman treatment. Given Azerbaijan’s bid to host COP 29 in 2024, I sincerely hope the United Nations will only agree if Baku releases all these prisoners."

Polman is one of the letter’s signatories, alongside former heads of state, such as Ernesto Zedillo, former President of Mexico; Mary Robinson, former President of Ireland; Oscar Arias, former President of Costa Rica and Nobel Peace Prize Laureate, and Elisha Wiesel, Chairman of the Board of the Elie Wiesel Foundation for Humanity and son of the late Elie Wiesel, former Co-Chair of Aurora Prize for Awakening Humanity. Other prominent signatories represent a wide range of sectors, including Richard Branson, CEO of Virgin, Marc Benioff, CEO of Salesforce; Ariana Huffington, founder of Thrive and The Huffington Post; and Serj Tankian, renowned musician and lead vocalist of System of a Down.

"The unjust detention of Ruben Vardanyan and so many others being held in Baku violates their basic human rights," said Mary Robinson, Former UN High Commissioner of Human Rights. "For the government of Azerbaijan to be respected in the global community, it is critical they respect the rule of law, especially in light of the ethnic cleansing of Nagorno-Karabakh. They must release these detainees immediately."

Their unified plea serves as a powerful reminder that global political leaders are closely monitoring developments in Azerbaijan and calling for the release of the detainees. As asserted in the letter issued today, the detention of Armenian prisoners is a clear violation of international norms, including the Third Geneva Convention.

In recent weeks, members of the European Parliament and European Council have pursued a peace agreement between Armenia and Azerbaijan and the release of all illegally held detainees arising from the conflict in Nagorno Karabakh. In October, the European Parliament passed a resolution calling on Azerbaijan to release and commit to a broad amnesty for all the inhabitants of Nagorno-Karabakh who have been arrested since September 19, including former officials from the region. The European Parliament has also called for sanctions against the individuals in the Azerbaijani Government responsible for multiple ceasefire violations and violations of human rights in Nagorno-Karabakh, as well as investigations into the abuses committed by Azerbaijani forces that could constitute war crimes.

Similarly, Congressman Adam Schiff (D-CA) introduced a resolution calling on Azerbaijan to immediately release all prisoners of war (POWs) and civilians currently detained in the years-long attack on Nagorno-Karabakh, also known as Artsakh. The resolution also calls on President Biden to impose sanctions under the Global Magnitsky Human Rights Accountability Act on Azerbaijani Government officials responsible for the illegal detention, torture, and extrajudicial killing of Armenian prisoners of war, civilian detainees, hostages, political prisoners, and others detained persons.

A full list of signatories and a copy of the letter are available at: www.FreeArmenianPrisoners.com

For questions about the letter or how to support this effort, or to request an interview, contact: [email protected]

CONTACT:

Nia Jackson 
Edelman Global Advisory
+1 202 983 0478
[email protected]

Anahit Akopian
H/Advisors
+33 7 87 38 79 80
[email protected]

Free Armenian Prisoners
[email protected]
www.FreeArmenianPrisoners.com
#FreeArmenianPrisoners @RubenVardanyan

Source : Over 150 Global Humanitarian, Business and Political Leaders Demand Freedom of "Armenian Prisoners"

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Dec. 12, 2023 /PRNewswire/ — A report from People’s Daily:Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee and Chinese President, will pay a state visit to Vietnam from Dec. 12 to 13.

Xi’s visit is at the invitation of General Secretary of the Communist Party of Vietnam Central Committee Nguyen Phu Trong and State President of the Socialist Republic of Vietnam Vo Van Thuong.

Six years after his last Vietnam trip, Xi’s upcoming visit is bound to open up new prospects for the relations between the two parties and the two countries and make new contributions to human peace and progress.

In their respective struggles for national liberation, China and Vietnam supported each other and forged a special bond of "camaraderie and brotherhood". The two countries’ traditional friendship has taken root as their peoples have lived in harmony over a long period. It was enhanced through their joint struggle for national independence and liberation, and continues to deepen as they pursue reform and renewal.

In recent years, the strategic guidance of Xi and Trong has added new dimensions to the traditional friendship between China and Vietnam and pushed for continuous new development of the comprehensive strategic cooperative partnership between the two countries.

After the 20th CPC National Congress last year, Xi invited Trong for a visit to China and the two leaders jointly charted the course for the China-Vietnam comprehensive strategic cooperative partnership. Since the beginning of this year, both countries have seen frequent high-level interactions, close exchanges between various departments and regions, and deeper cooperation in various fields, which have brought tangible benefits to the two peoples.

China and Vietnam are both advancing their own socialist modernization cause, both regard the bilateral relationship as a priority in their respective foreign policy, and both see each other’s development as opportunities for their own development.

Both countries are committed to a people-centered development philosophy, and are pursuing a path to prosperity and strength in line with their own national conditions. The two countries fully leverage their strengths in geographical proximity and industrial complementarity, advance the synergy between the Belt and Road Initiative and the "Two Corridors and One Economic Circle" plan, promote cooperation in strategic areas like connectivity and deepen collaboration in emerging sectors such as e-commerce.

During Xi’s upcoming visit, the two sides will discuss upgrading the China-Vietnam relations, focus on six major areas including politics, security, practical cooperation, public support, multilateral affairs and maritime issues, and work to deepen and substantiate the comprehensive strategic cooperation between the two countries. This will help both countries to jointly follow their modernization paths with respective features, enrich the paths to modernization for developing countries and bring more benefits to the two peoples.

China and Vietnam have the same social system and shared ideals and beliefs, and the bilateral relationship should be at the forefront compared to other countries.

Given the volatile international environment and tasks of reform, development and stability in the two countries, China and Vietnam should persevere in realizing their goals, ideals and missions for the people’s happiness and human progress, and continue to view and develop bilateral relations from a strategic and long-term perspective. Both countries should follow the policy of long-term stability, forward-thinking, good neighborliness and comprehensive cooperation, and the spirit of being good neighbors, friends, comrades and partners, so as to ensure the steady and sustained growth of bilateral relations in the new era.

The two sides should uphold the important position of the people in friendly exchanges, and inherit and carry forward the China-Vietnam traditional friendship. Both sides should, with a future-oriented perspective, make consistent efforts to promote mutual acquaintance, understanding and affinity among young people of the two countries.

As a Chinese saying goes, neighbors wish each other well, just as loved ones do to each other. The basic policy of China’s neighborhood diplomacy is to pursue friendship and partnership with its neighbors, and to build an amicable, secure and prosperous neighborhood, highlighting the principle of amity, sincerity, mutual benefit and inclusiveness.

China continues to regard the Association of Southeast Asian Nations (ASEAN) as a priority in its neighborhood diplomacy and a key region for high-quality Belt and Road cooperation, attaches importance to the position and role of Vietnam in ASEAN, and expects to work with Vietnam to accelerate the building of a peaceful, safe and secure, prosperous, beautiful and amicable home, and advance regional economic integration in East Asia.

China and Vietnam strengthen communication and cooperation in multilateral affairs, support each other on issues involving respective core interests and major concerns, jointly uphold multilateralism and international fairness and justice, and follow the basic norms governing international relations. This is of great significance for maintaining regional and world peace and stability and promoting common development.

The traditional friendship between China and Vietnam is a precious common treasure shared by the two peoples. Inheriting the past and ushering in the future, the two countries should stay true to the original aspiration of carrying forward traditional friendship, bear in mind the shared ideals and mission, continue to add new dimensions to their comprehensive strategic cooperative partnership, and inject new impetus into the development of relations between the two parties and countries.

Source : Xi's visit to Vietnam to open up new prospects for relations between two parties, two countries

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

DUBAI, UAE, Dec. 12, 2023 /PRNewswire/ — Bybit, the world’s third-largest crypto exchange by volume, introduces Aurora AI, an advanced AI-powered recommendation tool designed to simplify and elevate the bot trading experience for investors at every skill level.

Bybit Launches Aurora AI: Revolutionizing Bot Trading for All Investors

Empowering Investors with AI-Driven Strategies

Aurora AI simplifies the complexities of bot trading by harnessing the potential of artificial intelligence. This cutting-edge tool analyzes historical market data to identify 18 sets of optimal strategy parameters, emphasizing factors such as yield, arbitrage frequency, and drawdown risk.

Simplified Trading for Beginners and Masters Alike

Breaking down traditional barriers to entry, Aurora AI makes powerful bot trading strategies accessible to both novice and seasoned investors. Users can input their desired investment amount and copy the trading strategies provided by Aurora AI directly.

A proven track record with over 70% win rate

Bybit’s dedication to innovation is evident in Aurora AI’s outstanding track record. The Futures Grid Bot’s AI strategy boasts a win rate exceeding 70%, underscoring its effectiveness in generating consistent returns. Moreover, Aurora AI offers a diverse selection of strategies across various asset classes, enabling investors to tailor their approach to their unique needs.

"Bybit is committed to empowering traders with cutting-edge tools and technologies," remarked Ben Zhou, co-founder and CEO of Bybit. "The launch of Aurora AI marks a significant stride in our mission to make sophisticated trading strategies accessible to everyone. We are confident that Aurora AI will revolutionize the way investors interact with the market and help them achieve their financial goals."

#Bybit  #TheCryptoArk

About Bybit

Bybit is a top-three cryptocurrency exchange by volume with 20 million users established in 2018. It offers a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.

For media inquiries, please contact: [email protected]

For more information please visit: https://www.bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X (Twitter) | Youtube

Source : Bybit Launches Aurora AI: Revolutionizing Bot Trading for All Investors

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network